Open access
Novel 3,3′-diindolylmethane derivatives as multi-pathway modulators: targeting estrogen-dependent and independent breast cancer carcinogenesis
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.